US 9867785
Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
granted A61KA61K31/704A61K47/6879
Quick answer
US patent 9867785 (Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/704, A61K47/6879, A61K47/6901, A61K9/5068